Sendit

Sendit is a biotechnology company developing a programmable delivery platform for genetic medicines. Spun out of the Wyss Institute at Harvard University and MIT, the company utilizes Enveloped Delivery Vehicles (EDVs) to achieve precise, tissue-specific targeting of therapeutic cargoes. By engineering the surface of these vehicles, Sendit aims to overcome the delivery challenges associated with current lipid nanoparticle and viral vector technologies. The platform is designed to deliver a wide range of modalities, including mRNA, siRNA, and gene editing tools, to previously unreachable tissues. Sendit's technology has potential applications across oncology, immunology, and rare genetic disorders. The company is backed by leading life science investors and is headquartered in the Boston biotech ecosystem.